MAP2K1 and melanoma: An examination of the expression profiles of melanoma patients from the TCGA database, compared to normal controls from the GTEx database, revealed that AHR, MAP2K1, and PRKACB were upregulated in melanoma, whereas KLF5 and PIK3R2 were downregulated (Figure 4D).